Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Update on psychotropic medication use in renal disease Cohen LM; Tessier EG; Germain MJ; Levy NBPsychosomatics 2004[Jan]; 45 (1): 34-48Renal failure is a common medical condition, and many patients have comorbid psychiatric disorders. In this review, which is intended as a resource for consultation psychiatrists, the authors discuss pharmacokinetic considerations and provide information about the use of individual psychotropic medications in patients with renal disease. Most psychotropic medications are fat soluble, easily pass the blood-brain barrier, are not dialyzable, are metabolized primarily by the liver, and are excreted mainly in bile. Consequently, the majority of these drugs can be safely used with the end-stage renal disease population.|Anti-Anxiety Agents/pharmacokinetics[MESH]|Antidepressive Agents/pharmacokinetics[MESH]|Antipsychotic Agents/pharmacokinetics[MESH]|Comorbidity[MESH]|Half-Life[MESH]|Humans[MESH]|Kidney Diseases/*drug therapy/epidemiology[MESH]|Mental Disorders/epidemiology[MESH]|Mood Disorders/drug therapy[MESH]|Psychotropic Drugs/blood/pharmacokinetics/*therapeutic use[MESH]|Treatment Outcome[MESH] |